Recommendations from the EGAPP working group: Genomic profiling to assess cardiovascular risk to improve cardiovascular health

Genetics in Medicine

Volumn 12, Issue 12, 2010, Pages 839-843

[No Author Info available]

Author keywords

9p21; cardiovascular disease; genomic markers; modeling; risk factors

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; BEHAVIOR CHANGE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMOSOME 9P; CIGARETTE SMOKING; CLINICAL PRACTICE; CONSUMER; DIET; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; GENOMICS; HEALTH CARE SYSTEM; HEART DISEASE; LABORATORY TEST; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; OUTCOMES RESEARCH; POPULATION RISK; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK MANAGEMENT; STROKE; UNITED STATES; VALIDITY;

CARDIOVASCULAR DISEASES; GENETIC TESTING; HUMANS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 78650679343     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181f872c0     Document Type: Article

References (18)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:480-486.
2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics- 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
3. Mensah GA, Ryan US, Hooper WC, et al. Vascular endothelium summary statement II: cardiovascular disease prevention and control. Vascul Pharmacol 2007;46:318-320.
4. Hobbs FD. Cardiovascular disease: different strategies for primary and secondary prevention? Heart 2004;90:1217-1223.
5. World Heart Association. Cardiovascular disease risk factors. Available at: http:// www.worldheart.org/cardiovascular-health/cardiovascular-diseaserisk- factors, 2009. Accessed September 21, 2010.
6. van Wyk JT, van Wijk MA, Sturkenboom MC, Moorman PW, van der Lei J. Identification of the four conventional cardiovascular disease risk factors by Dutch general practitioners. Chest 2005;128:2521-2527.
7. American Heart Association. Risk factors and coronary heart disease. Available at: http://www.americanheart.org/presenter.jhtml?identifier=4726, 2009. Accessed September 21, 2010.
8. Teutsch SM, Bradley LA, Palomaki GE, et al. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group. Genet Med 2009;11:3-14.
9. World Health Organization. International statistical classification of diseases and related health problems. 10th Revision. Version for 2007. Available at: http://www.who.int/classifications/icd/en/, 2009. Accessed September 21, 2010.
10. Palomaki GE, Melillo S, Bradley LA. Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA 2010;303:648-656.
11. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172.
12. Sheridan SL, Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res 2008;8:60.
13. Sheridan SL, Viera AJ, Krantz MJ, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med 2010;170:230-239.
14. McBride CM, Bepler G, Lipkus IM, et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev 2002;11: 521-528.
15. Pijl M, Timmermans DR, Claassen L, et al. Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes: a randomized controlled trial. Diabetes Care 2009;32:597-599.
16. Arnett DK, Baird AE, Barkley RA, et al. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2007; 115:2878-2901.
17. Hlatky MA, Greenland P, Arnett DK, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408-2416.
18. Using nontraditional risk factors in coronary heart disease risk assessment: US Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:474-482.